Ospemifene has been authorized for the treatment of vulvovaginal atrophy (VVA). This study wasto evaluate adverse events (AEs) associated with ospemifene by data mining the US Food and Drug Administra
This dataset contains the minimal underlying data used to reproduce the findings of the study titled “Safety profile of fondaparinux based on the FAERS database: a disproportionality analysis”. The da
